Skip to content

Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction

Epigenetics and Prevention of Non-communicable Diseases in Kazakhstan: a Personalized Approach and Biological Age Prediction

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06953180
Enrollment
6720
Registered
2025-05-01
Start date
2025-03-03
Completion date
2026-12-31
Last updated
2025-07-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases (CVD), Chronic Kidney Diseases, Chronic Respiratory Diseases, Obesity (Disorder), Type 2 Diabetes

Keywords

DNA methylation, precision medicine, preventive medicine, artificial intelligence, biomedical modeling

Brief summary

This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.

Interventions

OTHERGenetic: DNA analysis

Investigation of telomere length (TL) and DNA methylation level analysis

Sponsors

Asfendiyarov Kazakh National Medical University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18 to 69 years. * Residents of 17 regions of Kazakhstan. * Willingness to participate and provide informed consent.

Exclusion criteria

* Age less than 18 years old or over 69 years old. * Failure to provide informed consent or incomplete participation in data collection procedures.

Design outcomes

Primary

MeasureTime frameDescription
Accuracy of Machine Learning Model for Predicting Biological AgeWithin 10 months from start of data collectionEvaluation of the model's performance (based on telomere length and DNA methylation) using Mean Absolute Error (MAE), Mean Squared Error (MSE), and R².
Accuracy of Reproductive Function Prediction ModelWithin 10 months from start of data collectionDevelopment and validation of machine learning model to predict reproductive function using biomarkers. Model performance evaluated via MAE, MSE, and R².

Countries

Kazakhstan

Contacts

Primary ContactIldar Fakhradiyev, Ph.D
fakhradiyev.i@kaznmu.kz+7 (727) 338 7090

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026